Evidence map›Paper›PMID 42193164›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Jia-Ying Chien, Wei-Hsun Chan, Mei-Ling Peng, Siu-Fung Chau, Hsien-Yang Tsai, Shi-Huang Lee, Yu-Chen Chen, Wai-Man Cheang, Shun-Ping Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jia-Ying ChienDepartment of Biochemical Science and Technology, National Chiayi University, Chiayi City 600355, Taiwan.ORCID 0009-0006-8732-2097
Wei-Hsun ChanDepartment of Biochemical Science and Technology, National Chiayi University, Chiayi City 600355, Taiwan.
Mei-Ling PengDepartment of Ophthalmology, Taichung Tzu Chi Hospital, Taichung 427213, Taiwan.
Siu-Fung ChauDepartment of Ophthalmology, Taichung Tzu Chi Hospital, Taichung 427213, Taiwan.
Hsien-Yang TsaiDepartment of Ophthalmology, Taichung Tzu Chi Hospital, Taichung 427213, Taiwan.
Shi-Huang LeeDepartment of Ophthalmology, Taichung Tzu Chi Hospital, Taichung 427213, Taiwan.
Yu-Chen ChenDepartment of Ophthalmology, Taichung Tzu Chi Hospital, Taichung 427213, Taiwan.
Wai-Man CheangDepartment of Ophthalmology, Taichung Tzu Chi Hospital, Taichung 427213, Taiwan.
Shun-Ping HuangDepartment of Biochemical Science and Technology, National Chiayi University, Chiayi City 600355, Taiwan.ORCID 0000-0002-6060-3095

Funding

National Science and Technology Council Taiwan 114-2314-B-415-001-MY3National Science and Technology Council Taiwan 114-2811-B-415-001
6 · The paper itself

Abstract

Non-arteritic anterior ischemic optic neuropathy (NAION) is a leading cause of sudden vision loss, yet no effective therapy exists to preserve retinal ganglion cells (RGCs) after ischemic injury.

Indexed as

cyanobacterianeuroinflammationneuroprotectionnon-arteritic anterior ischemic optic neuropathyNostoc communeoxidative stressPI3K/AKT/mTOR/p70S6Kretinal ganglion cellsvisual evoked potential

Identifiers

PMID42193164
PMCPMC13203249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.